J Med Microbiol NEW Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BRETT, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BRETT, M. S.
Agricola
Right arrow Articles by BRETT, M. S.
J. Med. Microbiol. -- Vol. 50 (2001), 173-176
© 2001 Society for General Microbiology
ISSN 0022-2615


ANTIMICROBIAL RESISTANCE

Emergence of a high-level cefotaxime-resistant Streptococcus pneumoniae strain in New Zealand

MAGGIE S. BRETT

Communicable Disease Group, Institute of Environmental Science & Research, PO Box 50-348, Porirua, New Zealand

Corresponding author: Dr M.S. Brett (e-mail: maggie.brett{at}esr.cri.nz).

Received 28 March 2000; revised version received 28 July 2000; accepted 7 Aug. 2000.

Abstract

An increase in the number of cefotaxime-resistant pneumococci referred for surveillance to a central laboratory in New Zealand occurred in 1997–1998. The MIC of cefotaxime for 113 of 216 cefotaxime-resistant isolates of Streptococcus pneumoniae referred was >=4 mg/L. Most of the 113 isolates exhibited the same antibiotic resistance pattern and belonged to serotype 19F. To investigate the genetic relatedness of the isolates, 48 serotype 19F pneumococci with varying susceptibility to cefotaxime were further typed by macro-restriction analysis by use of pulsed-field gel electrophoresis. These results suggested that a multiresistant 19F strain of S. pneumoniae with high-level cefotaxime resistance had emerged from a pre-existing serotype 19F strain.




This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
D. C. Bean, R. B. Ikram, and J. D. Klena
Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae in Christchurch, New Zealand
J. Antimicrob. Chemother., July 1, 2004; 54(1): 122 - 129.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
P. C. Fuchs, A. L. Barry, and S. D. Brown
In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime
J. Antimicrob. Chemother., February 1, 2002; 49(2): 399 - 401.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2001 Society for General Microbiology.